Strategies for Continued Successful Treatment in Patients with 
Alzheimer’s Disease: An Overview of Switching Between Pharmacological Agents

INTRODUCTION: Alzheimer’s disease (AD) is the most common cause of dementia, characterized by a progressive decline in cognition and function. Current treatment options for AD include the cholines-terase inhibitors (ChEIs) donepezil, galantamine, and rivastigmine, as well as the N-methyl-D-aspartate...

Descripción completa

Detalles Bibliográficos
Autores principales: Blesa, Rafael, Toriyama, Kazuhiro, Ueda, Kengo, Knox, Sean, Grossberg, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142408/
https://www.ncbi.nlm.nih.gov/pubmed/29895249
http://dx.doi.org/10.2174/1567205015666180613112040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142408/
https://www.ncbi.nlm.nih.gov/pubmed/29895249
http://dx.doi.org/10.2174/1567205015666180613112040

Ejemplares similares